Haematology Market is Anticipated to Reach USD 2.96 Billion Globally by 2029, Industry Share, Size, Growth, Demand, Revenue Statistics and Segmentation Outlook

The rise in blood disorders and other diseases, the quick development of haematology technology, and the appearance of high throughput haematology analyzers are all factors in the expansion of the haematology market. One of the key factors influencing the market is the rising incidence of chronic blood illnesses, which is anticipated to increase demand for haematology analyzers.

| Source: Data Bridge Market Research Data Bridge Market Research

BOSTON, Sept. 20, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350 pages, titled as “Global Haematology Market” with 100+ market data Tables, Pie Charts, Graphs & Figures spread through Pages and easy-to-understand detailed analysis. This Haematology report comprises of most-detailed market segmentation, systematic analysis of major market players, trends in consumer and supply chain dynamics, and insights into new geographical markets. The Haematology report makes your organization up to date with profound knowledge of the global, regional and local market statistics. Furthermore, it endows with historic data, present market trends, environment, technological innovation, upcoming technologies, and the technical progress in the related industry. This market research report comprises several parameters which are thoroughly studied by the experts. The Haematology report provides company profiling of key players in this industry, carefully analyzing their core competencies, and drawing a competitive landscape for the market.

Data Bridge Market Research analyses that the hematology market which was USD 2.13 billion in 2021, would rocket up to USD 2.96 billion by 2029, and is expected to undergo a CAGR of 4.20% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download Exclusive Sample Report PDF (with All Related Graphs & Charts) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-haematology-market

Market Synopsis:-

Hematology analyzers are medical instruments that are used to classify and count the number of blood cells in a patient's blood sample. Differential white blood cell counts are also analyzed using these equipment. The features of haematology analyzers vary according to the different medical equipment, and users can specify which testing service or analysis they require depending on these features.

The market for haematology is likely to be driven by the rates for automated haematology instruments and the preferences for high-sensitivity point-of-care (POC) haematology tests. Rapid technology advancements, such as applying fundamental flow cytometry techniques and expanding high throughput haematology analyzers, are also projected to significantly impact the industry's drivers.

Opportunities

  • Rising research and development activities

Furthermore, growing R&D initiatives demonstrating the efficacies of haematology analyzers are anticipated to benefit market expansion. For instance, automated hematologic analyzers are frequently employed in medical laboratories, according to a paper published in February 2021 titled "Establishment of enhanced review criteria for haematology analyzers in cancer institutions." The haematology analyzers market segment for cell surface markers detection will grow as a result of the hospital environment.

Some of the major players operating in the haematology market are:

  • Siemens (Germany)
  • Abbott (U.S.)
  • Erba Mannheim (Germany)
  • Abaxis (U.S.)
  • Heska Corporation (U.S.)
  • Sysmex Corporation (Japan)
  • Danaher (U.S.)
  • Nihon Kohden Corporation (Japan)
  • Siemens (Germany)
  • Abbott (U.S.)
  • Boule Diagnostics (Sweden)
  • HORIBA (Japan)
  • Bio-Rad Laboratories Inc. (U.S.)
  • BioSystems (U.S.)
  • Diatron (Hungary)
  • Drew Scientific (U.S.)
  • EKF Diagnostics (U.K.)
  • Mindray Medical India Pvt. Ltd. (China)
  • Ortho Clinical Diagnostics (U.S.)

Get a Detailed 350 Pages Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-haematology-market

Recent Development

  • In June 2022, Thermo Fisher Scientific Inc., expanded its extensive line of automated connective tissue disease tests by releasing the new EliA RNA Pol III and EliA Rib-P blood tests to assist in the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematosus (SLE)
  • In May 2020, The DxH 690T haematology analyzer was introduced by Beckman Coulter, a division of Danaher Corporation, in the United States. It enables mid-volume laboratories to optimize uptime and streamline workflow.

Major Drivers: Haematology Market

  • Rise in chronic diseases

The rise in blood disorders and other diseases, the quick development of haematology technology, and the appearance of high throughput haematology analyzers are all factors in the expansion of the haematology market. One of the key factors influencing the market is the rising incidence of chronic blood illnesses, which is anticipated to increase demand for haematology analyzers.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of the haematology market is the rising healthcare expenditure which helps improve its infrastructure. Also, various government organizations aim to improve the healthcare infrastructure by increasing funding, which will further influence the market dynamics.

The investment made in the study would provide you access to information such as:

  • Haematology Market [Global – Broken-down into regions]
  • Regional level split [North America, Europe, Asia Pacific, South America, Middle East & Africa]
  • Country wise Market Size Split [of important countries with major market share]
  • Market Share and Revenue/Sales by leading players
  • Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, etc.
  • Market Size
  • Market Size by application/industry verticals
  • Market Projections/Forecast

To Gain More Insights into the Market Analysis, Visit @ https://www.databridgemarketresearch.com/reports/global-haematology-market

Segments Covered:-

The haematology market segmentation on the basis of product, reagent, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 By Application

  • Drug Testing
  • Auto Immune Disease
  • Cancer
  • Diabetes Mellitus
  • Infectious Disease

By Product

  • Haematology Analyzers
  • Flow Cytometers
  • Coagulation Analyzers
  • Slide Stainers
  • Centrifuges
  • Hemoglobinometers

By Reagent

  • Coagulation Reagents
  • Flow Cytometery Reagents
  • Immuno-Haematology Reagents

By End User

  • Hospitals
  • Clinical Testing Institutes
  • Patient Self-testing

Haematology Market Regional Analysis/Insights

The countries covered in the haematology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the haematology market due to the growing geriatric population and innovative medical technology adoption. Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and the growing demand of advanced medical technology.

TABLE OF CONTENTS

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse The Complete Table of Contents at https://www.databridgemarketresearch.com/toc/?dbmr=global-haematology-market

Explore More Healthcare Reports: -

  • Blood Plasma Market, By Type (Hyperimmune Globulin, Albumin, Factor VIII, Factor IX, Immunoglobulin and  Others), Mode of Delivery (Infusion Solutions, Gels, Sprays, Biomedical Sealants), Therapeutic Indication (Immunology, Oncology, Pulmonology, Rheumatology, Transplantation, Neurology, Hematology and Other), Application (Hypogammaglobulinemia, Immunodeficiency Diseases, Hemophilia, Von Willebrand's Disease (vWD) and Others), End User (Hospitals, Clinics and Other) https://www.databridgemarketresearch.com/reports/global-blood-plasma-market
  • Invisible Orthodontics Market, By Products and Services (Products & Services), Age Group (Adults, Teenagers & Children), Application (Malocclusion, Crowding, Excessive Spacing & Others), End User (Hospitals, Dental Clinics, Orthodontics Clinics & Others), Distribution Channel (Direct Sales & Third Party Distributors), Country (U.S., Canada & Mexico, Germany, Italy, U.K., France, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey & Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines & Rest of Asia-Pacific, Brazil, Argentina, Colombia and Rest of South America, South Africa & Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-invisible-orthodontics-market
  • Gene Synthesis Market, Product Type (Custom Gene Synthesis, Gene Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, Others), Method (PCR Based Enzyme Synthesis, CHIP Based DNA Synthesis, Solid Phase Synthesis), End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, Other), Distribution Channel (Direct Tender, Online Distribution, Third Party Distributors) https://www.databridgemarketresearch.com/reports/global-gene-synthesis-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com


Tags

Haematology Market Haematology Market shares Haematology Market size Haematology Market players

Related Links